Can we reverse the HIV/AIDS pandemic with an expanded response?

PubWeight™: 5.21‹?› | Rank: Top 1%

🔗 View Article (PMID 12114060)

Published in Lancet on July 06, 2002

Authors

John Stover1, Neff Walker, Geoff P Garnett, Joshua A Salomon, Karen A Stanecki, Peter D Ghys, Nicholas C Grassly, Roy M Anderson, Bernhard Schwartländer

Author Affiliations

1: Futures Group International, Glastonbury, CT, USA. j.stover@tfgi.com

Articles citing this

Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med (2006) 49.95

Integrating HIV prevention and treatment: from slogans to impact. PLoS Med (2005) 6.73

Rethinking prevention of HIV type 1 infection. Clin Infect Dis (2010) 4.19

Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ (2005) 3.83

Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One (2008) 3.32

Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis. Arch Intern Med (2008) 2.96

Tackling India's HIV epidemic: lessons from Africa. BMJ (2003) 1.96

The epidemiological impact of antiretroviral use predicted by mathematical models: a review. Emerg Themes Epidemiol (2005) 1.76

Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study. PLoS Med (2013) 1.73

Global Fund-supported programmes contribution to international targets and the Millennium Development Goals: an initial analysis. Bull World Health Organ (2007) 1.66

The XIV International AIDS Conference: a call for action ... now. CMAJ (2002) 1.44

Young and vulnerable: spatial-temporal trends and risk factors for infant mortality in rural South Africa (Agincourt), 1992-2007. BMC Public Health (2010) 1.41

The impact of New York City's 1975 fiscal crisis on the tuberculosis, HIV, and homicide syndemic. Am J Public Health (2006) 1.39

"Bundling" HIV prevention: integrating services to promote synergistic gain. Prev Med (2007) 1.24

Decision making for HIV prevention and treatment scale up: bridging the gap between theory and practice. Med Decis Making (2010) 1.04

Determining a cost effective intervention response to HIV/AIDS in Peru. BMC Public Health (2009) 0.98

Estimating the resources required in the roll-out of universal access to antiretroviral treatment in Zimbabwe. Sex Transm Infect (2011) 0.97

Factors Influencing Condom Use among Sexually Transmitted Infection Clinic Patients in Montego Bay, Jamaica. Open Reprod Sci J (2008) 0.93

Health workforce contributions to health system development: a platform for universal health coverage. Bull World Health Organ (2013) 0.93

Estimating the number of HIV infections averted: an approach and its issues. Sex Transm Infect (2008) 0.89

Expanding access to HIV prevention. AIDS Res Ther (2006) 0.84

Complexity, cofactors, and the failure of AIDS policy in Africa. J Int AIDS Soc (2009) 0.82

Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa. PLoS One (2014) 0.80

Achieving the potential of HIV prevention interventions: critical global need for collaborative dissemination efforts. AIDS (2009) 0.79

Systematic review: a review of adolescent behavior change interventions [BCI] and their effectiveness in HIV and AIDS prevention in sub-Saharan Africa. BMC Public Health (2017) 0.75

Articles by these authors

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99

Evidence-based, cost-effective interventions: how many newborn babies can we save? Lancet (2005) 18.87

Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science (2003) 12.26

Towards an improved investment approach for an effective response to HIV/AIDS. Lancet (2011) 11.89

Estimates of maternal mortality worldwide between 1990 and 2005: an assessment of available data. Lancet (2007) 11.59

Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet (2003) 10.74

GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64

Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet (2013) 8.46

Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci U S A (2004) 8.38

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet (2002) 7.64

HIV decline associated with behavior change in eastern Zimbabwe. Science (2006) 6.98

Integrating HIV prevention and treatment: from slogans to impact. PLoS Med (2005) 6.73

HIV-1 transmission, by stage of infection. J Infect Dis (2008) 6.57

Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS (2011) 6.26

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11

Methods and procedures for estimating HIV/AIDS and its impact: the UNAIDS/WHO estimates for the end of 2001. AIDS (2003) 5.88

Sub-Saharan Africa's mothers, newborns, and children: where and why do they die? PLoS Med (2010) 5.54

Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS (2006) 5.31

Causes of deaths in children younger than 5 years in China in 2008. Lancet (2010) 5.02

Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS (2003) 4.87

HIV prevention transformed: the new prevention research agenda. Lancet (2011) 4.23

Planning for smallpox outbreaks. Nature (2003) 4.16

Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet (2004) 4.13

HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08

Can the world afford to save the lives of 6 million children each year? Lancet (2005) 4.07

Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS (2010) 4.05

Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90

Will travel restrictions control the international spread of pandemic influenza? Nat Med (2006) 3.89

Estimates of HIV-1 prevalence from national population-based surveys as a new gold standard. Lancet (2003) 3.85

Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ (2005) 3.83

Public health. Public health risk from the avian H5N1 influenza epidemic. Science (2004) 3.71

Neonatal survival: a call for action. Lancet (2005) 3.44

Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Lancet (2013) 3.41

The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis. Lancet (2012) 3.41

Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr (2002) 3.40

Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination. J Natl Cancer Inst (2008) 3.33

Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One (2008) 3.32

Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection package 2009. Sex Transm Infect (2010) 3.14

Child mortality and HIV infection in Africa: a review. AIDS (2004) 3.02

Implications of a circulating vaccine-derived poliovirus in Nigeria. N Engl J Med (2010) 3.00

Real-time estimates in early detection of SARS. Emerg Infect Dis (2006) 2.87

Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment. PLoS Med (2007) 2.85

Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings. PLoS One (2007) 2.84

Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. Emerg Infect Dis (2005) 2.80

Sub-Saharan Africa's mothers, newborns, and children: how many lives could be saved with targeted health interventions? PLoS Med (2010) 2.77

The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Science (2006) 2.76

Scale-free networks and sexually transmitted diseases: a description of observed patterns of sexual contacts in Britain and Zimbabwe. Sex Transm Dis (2004) 2.75

Creating and validating an algorithm to measure AIDS mortality in the adult population using verbal autopsy. PLoS Med (2006) 2.70

HIV infection does not disproportionately affect the poorer in sub-Saharan Africa. AIDS (2007) 2.67

Global burden of disease 2005: call for collaborators. Lancet (2007) 2.64

Modelling the impact of migration on the HIV epidemic in South Africa. AIDS (2007) 2.63

Estimating the net effect of HIV on child mortality in African populations affected by generalized HIV epidemics. J Acquir Immune Defic Syndr (2005) 2.63

Impact and process evaluation of integrated community and clinic-based HIV-1 control: a cluster-randomised trial in eastern Zimbabwe. PLoS Med (2007) 2.56

Meeting international goals in child survival and HIV/AIDS. Lancet (2002) 2.55

Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS Med (2012) 2.54

Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med (2006) 2.52

The theoretical population-level impact of a prophylactic human papilloma virus vaccine. Epidemiology (2002) 2.49

Saving newborn lives in Asia and Africa: cost and impact of phased scale-up of interventions within the continuum of care. Health Policy Plan (2008) 2.48

Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol (2011) 2.41

Study of bias in antenatal clinic HIV-1 surveillance data in a high contraceptive prevalence population in sub-Saharan Africa. AIDS (2002) 2.36

The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med (2004) 2.36

Stillbirths: how can health systems deliver for mothers and babies? Lancet (2011) 2.28

Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Med (2006) 2.28

The burden of disease and injury in the United States 1996. Popul Health Metr (2006) 2.27

Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic? Lancet (2004) 2.20

Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. Bull World Health Organ (2006) 2.20

Overview of the Lives Saved Tool (LiST). BMC Public Health (2013) 2.13

Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLoS Med (2006) 2.10

Quantifying sexual exposure to HIV within an HIV-serodiscordant relationship: development of an algorithm. AIDS (2011) 2.10

Mathematical models in the evaluation of health programmes. Lancet (2011) 2.05

Assessing evidence for behaviour change affecting the course of HIV epidemics: a new mathematical modelling approach and application to data from Zimbabwe. Epidemics (2009) 2.05

Prevalences of sexually transmitted infections in young adults and female sex workers in Peru: a national population-based survey. Lancet Infect Dis (2012) 2.03

Health impacts of macroeconomic crises and policies: determinants of variation in childhood malnutrition trends in Cameroon. Int J Epidemiol (2006) 2.02

Estimates of child deaths prevented from malaria prevention scale-up in Africa 2001-2010. Malar J (2012) 2.00